Rua Bioscience, New Zealand's first Māori founded NZX-listed company, has received Good Manufacturing Practice certification from Medsafe, allowing it to manufacture medicinal cannabis products.
Khiron to Present at Canaccord Genuity s Virtual Cannabis Conference
News provided by
Share this article
Share this article
TORONTO, May 6, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ( Khiron or the Company ) (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that Chairman Chris Naprawa will present live at Canaccord Genuity s 2021 Virtual Cannabis Conference on Tuesday, May 11, 2021 at 1:00 p.m. EDT (10:00 a.m. PDT).
Webcast details:
PRESENTERS: Chris Naprawa, Chairman of Khiron Board of Directors
REGISTER LINK:
Recently Announced Khiron Highlights
With the start of medical cannabis insurance coverage in Colombia in December 2020, the Company filled approximately 135% more prescriptions in Q1 2021 than in all of 2020. Additionally, in Q1 2021, 60% of medical cannabis prescriptions filled in Colombia were fully covered by insurance.
Are Higher THC Levels In Legal Cannabis Becoming Too High
Apr 15, 2021 10:46 AM ET Legal Newswire POWERED BY LAW.COM
Most random recreational cannabis users would say, if asked, is having a higher level of THC give you a better high . The answer is Yes… and No . Different strains and different users have their own effects. Also, does a consumer really know the level of THC in the products they buy? Marijuana Business Daily addressing the recreational market said: A new study shows consumers are unable to identify cannabinoid levels in products they use. Further, 20-50 percent don t know the THC:CBD ratio of the products they normally use. This lack of consumer awareness could have implications for the safety and efficacy of therapeutic use and throws into question the reliance on self-reported cannabis potency in scientific studies. The research, carried out at the University of Waterloo in Ontario, aimed to gauge consumer understanding of THC and CBD levels of c